FIBROGEN INC - Common Stock, $0.01 par value (FGEN)

115 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q3 2024.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 45.9M shares of 101M outstanding shares and own 45.5% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (9.91M shares), ARMISTICE CAPITAL, LLC (6.8M shares), VANGUARD GROUP INC (5.88M shares), ACADIAN ASSET MANAGEMENT LLC (3.91M shares), BlackRock, Inc. (2.39M shares), 683 Capital Management, LLC (2.14M shares), JACOBS LEVY EQUITY MANAGEMENT, INC (2.11M shares), JPMORGAN CHASE & CO (1.67M shares), MARSHALL WACE, LLP (1.44M shares), and GSA CAPITAL PARTNERS LLP (1.1M shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.